Jun 30, 2026 07:18AM
May 7, 2026 07:18AM
Mar 27, 2026 04:16PM
Mar 18, 2026 07:46AM
Mar 17, 2026 07:17AM
Feb 11, 2026 04:41PM
Jan 14, 2026 07:53AM Monte Rosa Therapeutics (GLUE) PT Raised to $37 at Piper Sandler
Jan 7, 2026 02:25PM
Jan 7, 2026 02:25PM
Dec 21, 2025 04:00AM
Dec 17, 2025 04:28AM
Dec 16, 2025 10:38AM
Dec 16, 2025 07:01AM
Dec 16, 2025 06:03AM Wells Fargo Upgrades Monte Rosa Therapeutics (GLUE) to Overweight
Nov 10, 2025 02:33AM
Nov 6, 2025 07:06AM
Oct 24, 2025 07:00AM
Sep 15, 2025 12:02PM
Sep 15, 2025 08:16AM
Sep 15, 2025 07:01AM
Aug 7, 2025 07:04AM Monte Rosa Therapeutics, Inc. (GLUE) reported Q2 Revenue
Jun 10, 2025 07:00AM
May 8, 2025 07:05AM
Apr 28, 2025 07:05AM
Mar 20, 2025 09:39AM
Mar 20, 2025 07:04AM
Jan 10, 2025 07:05AM
Dec 13, 2024 07:00AM Monte Rosa Therapeutics (GLUE) Appoints Dr. Eric A. Hughes to Board of Directors
Dec 11, 2024 07:02AM
Dec 5, 2024 07:04AM
Nov 7, 2024 07:23AM
Nov 7, 2024 07:05AM
Oct 28, 2024 02:06PM
Oct 28, 2024 12:25PM
Oct 28, 2024 07:01AM Monte Rosa Therapeutics (GLUE) Announces Global License Agreement with Novartis (NVS) to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders
Oct 23, 2024 07:07AM
Aug 19, 2024 07:01AM
Aug 8, 2024 07:13AM
Jun 28, 2024 10:41AM
Jun 28, 2024 07:55AM
Jun 27, 2024 07:06AM
Jun 17, 2024 08:10AM Piper Sandler Reiterates Overweight Rating on Monte Rosa Therapeutics (GLUE)
Jun 14, 2024 08:46AM

430,621 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All